Remus Pharmaceuticals Ltd

NSE: REMUS · Pharmaceuticals & Biotechnology · 18 announcements

Share price

₹856.25

Market cap

₹1,009 Cr

Revenue (annual)

₹853.6 Cr

Net profit (annual)

₹36.99 Cr

P/E (TTM)

27.3×Sector 47.3×

Promoter holding

70.95%

FII holding

5.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.